Rivastigmine Tartrate

Product NDC
0781-2617
11-digit product format
007812617
Labeler code
0781
Product ID
0781-2617_3375f1a6-a261-4c5c-81ee-674a11cefaf8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rivastigmine tartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
Sandoz Inc
Application
NDA020823
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2000-04-30
Marketing end
0000-00-00
Substance
RIVASTIGMINE TARTRATE
Active strength
6 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0781-2617-602020-10-07C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb
0781-2617-602020-01-31C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-2617-13EA - Each0781-261790dba6f7-4afe-43c9-b605-ea300f991c2912012-07-24
0781-2617-60EA - Each0781-26176bc8decf-32ae-4d38-b785-e65fc9c8338b12012-07-24